“Industry-Academia Collaboration Results”: Ceragem’s Joint Research with Pusan National University and Others Published in International Journal

[Financial News] Ceragem has published the results of research on blood-flow measurement technology conducted jointly with the Korea Advanced Institute of Science and Technology (KAIST) and Pusan National University in an international journal. The company plans to build scientific evidence for its healthcare technologies through industry-academia collaboration and apply it to medical device research and development.
 According to industry sources on the 9th, results from research conducted jointly by Ceragem, the KAIST Future Healthcare Research Center and researchers at Pusan National University appeared in the October issue of *Current Optics and Photonics*, an international journal in the fields of optics and photonics.
 The study was conducted to assess how reliably laser-based blood-flow measurement technology operates in different environments. The researchers analyzed how changes in flow were reflected in laser measurements as liquid flowed through various types of blood vessel models.
 They found that changes in the liquid’s flow were reflected in the measurement signals. However, the strength and stability of the signals varied depending on the blood vessel structure and skin conditions. This shows that the characteristics of both blood vessels and skin need to be taken into account to improve the accuracy and reliability of blood-flow measurement technology.
 A Ceragem spokesperson said, “This research confirmed that changes in blood flow can be measured using a laser, and that measurement results can vary depending on blood vessel structure and skin conditions.” The spokesperson added, “On this basis, we established an experimental foundation for systematically evaluating the performance and reliability of blood-flow measurement technology.”
 Ceragem plans to apply the results of this and other industry-academia collaborations to its in-house healthcare device research and development. Alongside basic research on blood-flow measurement technology, it is also conducting clinical studies to verify the effects of using its medical devices.
 One notable example is the Celltron Circulation Chair, a medical device designed to improve blood circulation. The chair-shaped device uses electrical-potential and heat therapy technologies and has been certified by the Ministry of Food and Drug Safety for two intended uses: improving blood circulation and relieving muscle pain.
 The electrical-potential function applies an alternating electric field to the body to help improve blood circulation. The heat therapy function, applied to the back, lower back and hips, raises the temperature to a maximum of 60 degrees to help relieve muscle pain.
 Last August, Ceragem also released the results of its own exploratory clinical trial of the Celltron Circulation Chair. After 40 adults used the product for 30 minutes, measurements of blood flow on the backs of their hands showed an average increase of 8.01% compared with before use. However, the study was an exploratory clinical trial conducted at a single institution and did not verify the long-term effects of use.
 A Ceragem spokesperson said, “We will continue to build scientific evidence related to healthcare technologies through industry-academia collaboration and develop healthcare technologies that consumers can trust.”
[email protected] Kang Gyeong-rae Reporter